MLTX SECURITIES NOTICE: Securities Fraud Allegations Hit MoonLake Immunotherapeutics – Investors have Until December 15 to Contact BFA Law
NEW YORK CITY, NY / ACCESS Newswire / October 29, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ:MLTX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged […]